arrow
C

Carsten Müller-Tidow

University of Heidelberg
H指数:86
被引数:3.1万

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

A distinct CAR-T cell phenotype mediates therapeutic response at limited doses

一种独特的CAR-T细胞表型介导了有限剂量下的治疗效果

2026-07-290
OA
Author Correction: Teclistamab-based induction treatment in transplant-eligible, newly diagnosed multiple myeloma: a phase 2 trial

作者更正: 基于Teclistamab的诱导治疗符合移植条件的新诊断多发性骨髓瘤: 2期试验

2026-07-060
OAAI
Clinical decision support in hematological malignancies using a case-grounded AI agent

基于案例支持的AI代理在血液恶性肿瘤中的临床决策支持

2026-06-300
OAAI
Teclistamab-based induction treatment in transplant-eligible, newly diagnosed multiple myeloma: a phase 2 trial

基于Teclistamab的诱导治疗可移植的新诊断多发性骨髓瘤: 一项2期试验

2026-06-250
OAAI
High-risk single-refractory and double-refractory chronic lymphocytic leukemia: feasibility and impact of alloHCT

高危单药难治性和双药难治性慢性淋巴细胞白血病:异基因造血干细胞移植的可行性与影响

2026-06-150
OAAI
Reprogramming of stroma-derived chemokine networks drives the loss of tissue organization in nodal B cell lymphoma

基质衍生的趋化因子网络的重编程驱动结节b细胞淋巴瘤中组织组织的丧失

2026-03-250
OAAI
PRDM16 expression is an independent prognostic factor in AML with the double-mutant NPM1/FLT3-ITD genotype

PRDM16表达是双突变NPM1/FLT3-ITD基因型AML的独立预后因素

2026-01-220
OAAI
Author Correction: Loss of the histone methyltransferase EZH2 induces resistance to multiple drugs in acute myeloid leukemia

作者更正:组蛋白甲基转移酶EZH2的丢失诱导急性髓系白血病对多种药物的耐药性

2026-01-070
OAAI
Structured whole-body MRI highlights clinically relevant disease pattern changes in relapsed/refractory multiple myeloma

结构化全身MRI突显了复发/难治性多发性骨髓瘤临床相关疾病模式的变化。

Leukemia
IF13.4
2025-12-220
OAAI
Characterization, outcome and identification of prognostic factors for patients with systemic immunoglobulin light-chain amyloidosis requiring dialysis prior to initial anti-clonal therapy

系统性免疫球蛋白轻链淀粉样变性患者在初始抗克隆治疗前行透析治疗时的特征、结局及预后因素识别

2025-12-010
OA
Dynamic Ribosomal RNA Methylation Regulates Translation in the Hematopoietic System and is Essential for Stem Cell Fitness

动态核糖体RNA甲基化调控造血系统中的翻译,并且对干细胞适应性至关重要。

Blood
IF23.1
2025-11-070
PRE
Differential prognostic impact of myelodysplasia-related gene mutations in a European cohort of 4978 intensively treated AML patients

4978例接受强化治疗的AML欧洲患者队列中,髓系发育异常相关基因突变的不同预后影响

Leukemia
IF13.4
2025-10-270
OA
Prospective systematic classification of causes of death in the course of multiple myeloma

多发性骨髓瘤病程中死亡原因的前瞻性系统分类

2025-10-200
OA